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Nanonization is a proven effective strategy to enhance the dissolution rate of poorly water-
soluble drugs such as BCS class II (poorly soluble and good permeable) and Class IV (poorly 
soluble and poor permeable) pharmacons, thus their bioavailability can be improved [1]. To 
overcome the instability of the nanosuspensions and also to improve the patient compliance 
could be the transformation of the product into solid dosage form. In this case it is necessary 
to ensure the rapid dissolution characteristics of the nanoparticles [2]. 
Our aims were, to optimize a combined wet milling process, and to formulate solid dosage 
forms for oral drug administration with rapid dissolution characteristics. The formulation 
processes were manual granulation, fluidization and lyophylisation. 
Meloxicam (Mel) was used as a model active pharmaceutical agent. During the wet milling 
process aqueous PVA solution was used as the stabilizing agent. The additives used in 
formulation processes were Avicel, Kollidon, Aerosil, Mannitol, Comprecel and Trehalose. 
The optimisation process was successfully executed. The granules produced by manual 
granulation showed sustained release. The lyophilisates and the granules made by fluid bed 
granulation had rapid dissolution characteristics. 
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